Orsolya K.
- Country
- Hungary
- Department
- Gyermekgyogyaszati Klinika Gasztroenterologia Osztaly
Research Overview
- A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
- A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib with Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy
- A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age with Functional Constipation (FC).
Data & Insights
Has run more than one trial at 25 of 69 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating pediatric inflammatory bowel diseases, with particular emphasis on both ulcerative colitis and Crohn's disease. Their research encompasses various therapeutic approaches for managing these conditions in young patients.
- Moderate to Severe Ulcerative Colitis Treatment
- Crohn's Disease Interventions
- Long-term Disease Management
Their work involves evaluating novel biological treatments and investigating long-term therapeutic outcomes in pediatric populations.
Pediatric Gastroenterology
The investigator focuses on gastrointestinal disorders in children, with particular attention to functional constipation in very young patients. Their expertise extends to treating various digestive system conditions in pediatric populations.
- Early Childhood Gastrointestinal Disorders
- Functional Constipation Management
- Digestive System Therapeutics
Their research includes investigating treatments for infants and toddlers with gastrointestinal conditions.
Advanced Therapeutic Applications
The investigator evaluates innovative therapeutic approaches including biological agents and small molecule treatments for pediatric autoimmune conditions. Their work encompasses both intravenous and subcutaneous administration methods.
- Biological Therapy Assessment
- Novel Treatment Protocols
- Long-term Safety Evaluation
Their research focuses on establishing effective treatment protocols for chronic inflammatory conditions in children.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.